ReWalk Robotics Ltd Total Liabilities

Latest as of June 2026: $22.78 Million USD

ReWalk Robotics Ltd total liabilities. Based on the latest financial reports, ReWalk Robotics Ltd (LFWD) has total liabilities worth $22.78 Million USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See LFWD days of operational coverage to measure how many days the company can operate on defensive assets alone.

Total Liabilities of ReWalk Robotics Ltd (2016–2025)

Total liabilities of ReWalk Robotics Ltd from 2016 to 2025. This chart illustrates how ReWalk Robotics Ltd's total liabilities have evolved over time, based on quarterly financial data.

ReWalk Robotics Ltd Competitors by Total Liabilities

The table below lists competitors of ReWalk Robotics Ltd ranked by their total liabilities.

Company Country Total Liabilities
Flow Capital Corp
V:FW
Canada CA$52.62 Million
Mesiniaga Bhd
KLSE:5011
Malaysia RM132.19 Million
Cavendish Hydrogen ASA
OL:CAVEN
Norway Nkr12.70 Million
SAMJIN Co. Ltd
KQ:032750
Korea ₩15.24 Billion
Micro-X Ltd
AU:MX1
Australia AU$11.82 Million
Zodiac Energy Limited
NSE:ZODIAC
India Rs-965.64 Million
Freeport Resources Inc
V:FRI
Canada CA$93.15K
Inter Rock Minerals Inc
V:IRO
Canada CA$16.51 Million

Liability Composition Analysis (2016–2025)

This chart breaks down ReWalk Robotics Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see LFWD asset base.

Liquidity & Leverage Metrics

ReWalk Robotics Ltd Total Liabilities Ratios Explained

ReWalk Robotics Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 1.24 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 1.87 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.65 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how ReWalk Robotics Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for ReWalk Robotics Ltd (2016–2025)

The table below shows the annual total liabilities of ReWalk Robotics Ltd from 2016 to 2025.

Year Total Liabilities Change
2025-12-31 $14.49 Million +24.52%
2024-12-31 $11.64 Million -30.24%
2023-12-31 $16.68 Million 0.00%
2023-09-30 $16.68 Million +174.78%
2022-12-31 $6.07 Million 0.00%
2022-09-30 $6.07 Million +13.12%
2021-12-31 $5.37 Million 0.00%
2021-09-30 $5.37 Million -14.71%
2020-12-31 $6.29 Million 0.00%
2020-09-30 $6.29 Million -53.70%
2019-12-31 $13.59 Million +4.42%
2018-12-31 $13.02 Million -32.05%
2017-12-31 $19.16 Million -18.50%
2016-12-31 $23.50 Million --

About ReWalk Robotics Ltd

NASDAQ:LFWD USA Medical Devices
Market Cap
$16.51 Million
Market Cap Rank
#25546 Global
#5401 in USA
Share Price
$5.83
Change (1 day)
-3.80%
52-Week Range
$0.43 - $8.73
All Time High
$2955.75
About

Lifeward Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, Germany, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices for individuals with spinal… Read more